<Purpose>
This article examines clinical and patient-reported outcomes in breast cancer patients post-mastectomy, comparing those undergoing implant-based versus autologous breast reconstruction. Additionally, the study explores relevant predictors to offer improved decision-making guidance for patients considering these reconstruction options.
<Material and Methods>
Between 2016 and 2022, data were collected from a retrospective cohort of 283 breast cancer patients who underwent breast reconstruction post-mastectomy. Among them, 161 patients opted for implant-based reconstruction, while the remaining 122 chose autologous breast reconstruction. Postoperative analyses were conducted to compare outcomes, and patient-reported satisfaction was assessed by using the BreastQ questionnaire.
<Results>
In the cohort of patients undergoing autologous breast reconstruction, a heightened percentage elected to receive postoperative radiotherapy and chemotherapy. The overall incidence of complications did not achieve statistical significance. Nevertheless, within the implant-based group, there was an elevated prevalence of wound infections, whereas the autologous group demonstrated a higher proportion of patients necessitating further surgical interventions attributable to complications or cosmetic considerations. Regarding patient-reported outcomes assessed through the BreastQ questionnaire, the autologous group exhibited superior satisfaction levels in sexual well-being, satisfaction with breasts, and satisfaction with chest when compared with the implant-based group.
<Conclusions>
Despite the increased risk of subsequent surgeries observed in patients undergoing autologous breast reconstruction, the evident superiority in patient-reported outcomes over implant-based breast reconstruction highlights the favorable nature of autologous approaches.